Sp63
THE PROMISE AND PITFALLS OF BRINGING NEW BARRETT'S TOOLS TO MARKET
Date
May 18, 2024
Presenter
University of North Carolina
Tracks
Related Products
Charles S. Lieber Lecture: New Frontiers in Risk Stratification to Improve Outcomes in Esophageal Cancer
This AGA session on Barrett's esophagus and esophageal adenocarcinoma will provide a state of the art update on screening, surveillance and endoscopic eradication therapy…
‘INCIDENTAL’ BARRETT’S ESOPHAGUS IS ASSOCIATED WITH HIGH RATES OF NEOPLASIA AND LOW RATES OF ADHERENCE TO QUALITY INDICATORS: A POPULATION-BASED ANALYSIS USING THE GIQUIC NATIONAL QUALITY BENCHMARKING REGISTRY
‘Incidental’ BE, defined as BE diagnosed during exams for reasons other than BE screening or surveillance, has unknown incidence and outcomes. Patient characteristics, detection of dysplasia, and adherence to established quality indicators in this patient population has not been described…
